Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
Ayabe R, Rootman DB, Hwang CJ, Ben-Artzi A, Goldberg R. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2014 Sep-Oct; 30(5):415-9.